|
|
|
|
| LEADER |
00835nam a2200229 a 4500 |
| 001 |
000374037 |
| 003 |
CZ BrMZK |
| 005 |
20040419135809.0 |
| 007 |
ta |
| 008 |
010907s1985 sz f eng d |
| 040 |
|
|
|a BOA001
|b cze
|
| 080 |
|
|
|a 615.277
|2 MRF
|
| 080 |
|
|
|a 616-006-085
|2 MRF
|
| 245 |
0 |
0 |
|a New Aspects in Physiolgical Antitumor Substances :
|b experimental and clinical studies with xenogenic peptides and proteins : 1. Oncology Workshop... in Ludwigsburg (FRG), 26. August 1983 /
|c Ed. G. Gillissen, K. E. Theurer.
|
| 260 |
|
|
|a Basel :
|b S. Karger,
|c 1985
|
| 300 |
|
|
|a 10, 227 s.
|
| 500 |
|
|
|a Souhrny též něm.
|
| 700 |
1 |
|
|a Gillissen, G.
|4 edt
|
| 700 |
1 |
|
|a Theurer, Karl E.
|4 edt
|
| 910 |
|
|
|a BOA001
|b 2-0924.502
|
| 990 |
|
|
|a BK
|
| 996 |
7 |
|
|b 2619334055
|c 2-0924.502
|l MZK
|r Sklad / do 1 hodiny
|n 0
|w 000374037
|u 000010
|a 1
|e BOA001
|j MZK50
|s A
|
English 
Čeština 
